LISI GROUP - Integrated report 2020

STATEMENT OF COMPREHENSIVE INCOME (in thousands of euros) 12/31/2020 12/31/2019 PROFIT (LOSS) FOR THE PERIOD (37,544) 73,812 OTHER ITEMS OF OVERALL INCOME APPLIED TO SHAREHOLDERS’ EQUITY Actuarial gains and losses out of employee benefits (gross element) 6,693 (4,853) Actuarial gains and losses out of employee benefits (tax impact) (1,876) 1,446 Restatements of treasury shares (gross element) (227) 258 Restatements of treasury shares (tax impact) 59 (75) OTHER ITEMS OF OVERALL INCOME THAT WILL CAUSE A RECLASSIFICATION OF INCOME Exchange rate differences resulting from foreign business (30,116) 9,413 Hedging instruments (gross element) 6,667 3,954 Hedging instruments (tax impact) (1,963) (675) TOTAL OTHER PORTIONS OF GLOBAL EARNINGS FOR THE PERIOD, AFTER TAXES (20,764) 9,467 TOTAL OVERALL INCOME FOR THE PERIOD (58,308) 83,279 INCOME STATEMENT (in thousands of euros) Notes 12/31/2020 12/31/2019 PRE-TAX SALES 3.6.1 1,229,958 1,729,527 Changes in stock, finished products and production in progress (22,442) (3,513) TOTAL PRODUCTION 1,207,515 1,726,014 Other revenues* 39,507 28,508 TOTAL OPERATING REVENUES 1,247,022 1,754,522 Consumed goods 3.5.2 (321,007) (476,490) Other purchases and external expenses 3.5.3 (265,251) (349,499) Taxes and duties (12,317) (11,995) Employee benefits expense (including temps) 3.5.4 (481,762) (643,338) EBITDA 166,685 273,200 Depreciation (117,095) (119,181) Net provisions (8,082) 1,094 CURRENT OPERATING PROFIT (EBIT) 41,509 155,113 Non-recurring operating income and expenses 3.5.6 (69,618) (44,835) OPERATING PROFIT (28,109) 110,278 FINANCING EXPENSES AND REVENUE ON CASH 3.5.7 (5,164) (4,326) Revenue on cash 3.5.7 1,231 3,544 Financing expenses 3.5.7 (6,396) (7,871) OTHER INTEREST REVENUE AND EXPENSES 3.5.7 (11,595) (4,221) Other financial items 3.5.7 31,866 26,688 Other interest expenses 3.5.7 (43,461) (30,909) Taxes (of which CVAE (Tax on companies’ added value))* 3.5.8.1 7,323 (27,918) PROFIT (LOSS) FOR THE PERIOD (37,544) 73,812 Attributable as company shareholders’ equity (37,321) 69,773 Interest not granting control over the company (223) 4,039 EARNINGS PER SHARE (IN €) 3.5.9 (0.71) 1.31 DILUTED EARNINGS PER SHARE (IN €) 3.5.9 (0.70) 1.30 * In order to provide readers of the financial statements with better information that is in accordance with international standards, in the 2020 financial statements the company has continued classifying revenues related to CIR (Research Tax Credit) as “Other income”, for an amount of €5.7 million in 2020, compared to €5.2 million in 2019. FINANCIAL DATA 6 _ DISTRIBUTION OF VALUE